CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Akebia Therapeutics against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Methods Of Increasing Endogenous Erythropoietin (Epo)FIBROGENFeb 10, 2020
Medicaments For Increasing Endogenous Erythropoietine (Epo)FIBROGENApr 3, 2019
Medicaments For Increasing Endogenous Erythropoietin (Epo)FIBROGENApr 3, 2019
Use Of Hif Alpha Stabilizers For Enhancing ErythropoiesisFIBROGENJul 6, 2015

Explore Akebia Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 7, 2024Compositions And Methods For Treating Anemia1
May 11, 2022Prolyl Hydroxylase Inhibitors And Methods Of Use1
Oct 27, 2021Compositions And Methods For Treating Anemia1

Top competitors of Akebia Therapeutics

List of top competitors of Akebia Therapeutics based on patent oppositions.